Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring

Journal of Clinical Virology

Volumn 58, Issue 2, 2013, Pages 415-421

  Khamduang, Woottichai ^a,b,c   Gaudy Graffin, Catherine ^b   Ngo Giang Huong, Nicole ^a,c,d   Jourdain, Gonzague ^a,c,d   Moreau, Alain ^b   Borkird, Thitiporn ^e   Layangool, Prapaisri ^f   Kamonpakorn, Nareerat ^g   Jitphiankha, Weerachai ^h   Kwanchaipanich, Ratchanee ⁱ   Potchalongsin, Sathit ^j   Lallemant, Marc ^a,c,d   Sirirungsi, Wasna ^a   Goudeau, Alain ^b  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b UNIVERSITÉ DE TOURS   (France)

^c IRD URI 174/Program for HIV Prevention and Treatment   (Thailand)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e Hat Yai Hospital   (Thailand)

^f BHUMIBOL ADULYADEJ HOSPITAL   (Thailand)

^g Somdej Prapinklao Hospital   (Thailand)

^h Health Promotion Center   (Thailand)

ⁱ Chachoengsao Hospital   (Thailand)

^j Nongkhai Hospital   (Thailand)

more..

Author keywords

HBs antigen variants; Hepatitis B vaccine failure; HIV pregnant women; Mother to child transmission; Thailand

Indexed keywords

HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; NEVIRAPINE; VIRUS DNA; ZIDOVUDINE;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FEMALE; GENETIC ANALYSIS; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MIXED INFECTION; PERINATAL INFECTION; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; SINGLE DRUG DOSE; THAILAND; VERTICAL TRANSMISSION; VIREMIA; VIRUS LOAD;

95% CONFIDENCE INTERVAL; 95%CI; DEOXYRIBONUCLEIC ACID; DNA; EPI; EXPANDED PROGRAM ON IMMUNIZATION; HB; HBEAG; HBIG; HBS ANTIGEN VARIANTS; HBSAG; HBV; HEPATITIS B; HEPATITIS B IMMUNE GLOBULIN; HEPATITIS B VACCINE FAILURE; HEPATITIS B VIRUS; HIV; HIV PREGNANT WOMEN; HUMAN IMMUNODEFICIENCY VIRUS; INTERQUARTILE RANGE; IQR; MOTHER-TO-CHILD TRANSMISSION; MTCT; PCR; POLYMERASE CHAIN REACTION; THAILAND; THE " E" ANTIGEN OF THE HEPATITIS B VIRUS; THE SURFACE ANTIGEN OF THE HEPATITIS B VIRUS;

ADULT; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; THAILAND; YOUNG ADULT;

EID: 84884532836     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.06.025     Document Type: Article

References (35)

1. World Health Organization (WHO) Hepatitis B: Fact sheet No. 204 2012, [revised July 2012].
2. Heathcote E.J. Demography and presentation of chronic hepatitis B virus infection. Am J Med 2008, 121:S3-S11.
3. Liaw Y.F., Leung N., Kao J.H., Piratvisuth T., Gane E., Han K.H., et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008, 2:263-283.
4. Kew M.C. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris) 2010, 58:273-277.
5. Chen H.L., Lin L.H., Hu F.C., Lee J.T., Lin W.T., Yang Y.J., et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 2012, 142:773-81e2.
6. Poovorawan Y., Theamboonlers A., Vimolket T., Sinlaparatsamee S., Chaiear K., Siraprapasiri T., et al. Impact of hepatitis B immunisation as part of the EPI. Vaccine 2000, 19:943-949.
7. Hunt C.M., McGill J.M., Allen M.I., Condreay L.D. Clinical relevance of hepatitis B viral mutations. Hepatology 2000, 31:1037-1044.
8. Oon C.J., Lim G.K., Ye Z., Goh K.T., Tan K.L., Yo S.L., et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995, 13:699-702.
9. Komatsu H., Inui A., Sogo T., Konishi Y., Tateno A., Fujisawa T. Hepatitis B surface gene 145 mutant as a minor population in hepatitis B virus carriers. BMC Res Notes 2012, 5:22.
10. Lallemant M., Jourdain G., Le Coeur S., Kim S., Koetsawang S., Comeau A.M., et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 2000, 343:982-991.
11. Lallemant M., Jourdain G., Le Coeur S., Mary J.Y., Ngo-Giang-Huong N., Koetsawang S., et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004, 351:217-228.
12. Villeneuve J.P., Durantel D., Durantel S., Westland C., Xiong S., Brosgart C.L., et al. Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient. J Hepatol 2003, 39:1085-1089.
13. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596-1599.
14. Kay A., Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res 2007, 127:164-176.
15. Purdy M.A., Talekar G., Swenson P., Araujo A., Fields H. A new algorithm for deduction of hepatitis B surface antigen subtype determinants from the amino acid sequence. Intervirology 2007, 50:45-51.
16. Goudeau A., Yvonnet B., Lesage G., Barin F., Denis F., Coursaget P., et al. Lack of anti-HBc IgM in neonates with HBsAg carrier mothers argues against transplacental transmission of hepatitis B virus infection. Lancet 1983, 2:1103-1104.
17. Shao Z.J., Zhang L., Xu J.Q., Xu D.Z., Men K., Zhang J.X., et al. Mother-to-infant transmission of hepatitis B virus: a Chinese experience. J Med Virol 2011, 83:791-795.
18. Song Y.M., Sung J., Yang S., Choe Y.H., Chang Y.S., Park W.S. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007, 166:813-818.
19. Zou H., Chen Y., Duan Z., Zhang H. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers. PLoS ONE 2011, 6:e26748.
20. Pan C.Q., Duan Z.P., Bhamidimarri K.R., Zou H.B., Liang X.F., Li J., et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol 2012, 10:452-459.
21. Lee C., Gong Y., Brok J., Boxall E.H., Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006, 332:328-336.
22. Sa-Nguanmoo P., Tangkijvanich P., Tharmaphornpilas P., Rasdjarmrearnsook A.O., Plianpanich S., Thawornsuk N., et al. Molecular analysis of hepatitis B virus associated with vaccine failure in infants and mothers: a case-control study in Thailand. J Med Virol 2012, 84:1177-1185.
23. Tian Y., Xu Y., Zhang Z., Meng Z., Qin L., Lu M., et al. The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol 2007, 45:2971-2978.
24. Velu V., Saravanan S., Nandakumar S., Dhevahi E., Shankar E.M., Murugavel K.G., et al. Transmission of "a" determinant variants of hepatitis B virus in immunized babies born to HBsAg carrier mothers. Jpn J Infect Dis 2008, 61:73-76.
25. Lee K.M., Kim Y.S., Ko Y.Y., Yoo B.M., Lee K.J., Kim J.H., et al. Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. J Korean Med Sci 2001, 16:359-362.
26. Cheng H., Su H., Wang S., Shao Z., Men K., Li M., et al. Association between genomic heterogeneity of hepatitis B virus and intrauterine infection. Virology 2009, 387:168-175.
27. Ren F., Tsubota A., Hirokawa T., Kumada H., Yang Z., Tanaka H. A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change. Gene 2006, 383:43-51.
28. Mele A., Tancredi F., Romano L., Giuseppone A., Colucci M., Sangiuolo A., et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 2001, 184:905-908.
29. Theamboonlers A., Chongsrisawat V., Jantaradsamee P., Poovorawan Y. Variants within the "a" determinant of HBs gene in children and adolescents with and without hepatitis B vaccination as part of Thailand's Expanded Program on Immunization (EPI). Tohoku J Exp Med 2001, 193:197-205.
30. Ogata N., Cote P.J., Zanetti A.R., Miller R.H., Shapiro M., Gerin J., et al. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus. Hepatology 1999, 30:779-786.
31. Jones C.E., Naidoo S., De Beer C., Esser M., Kampmann B., Hesseling A.C. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 2011, 305:576-584.
32. Hsu H.Y., Chang M.H., Ni Y.H., Chiang C.L., Chen H.L., Wu J.F., et al. No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. J Infect Dis 2010, 201:1192-1200.
33. Ilboudo D., Simpore J., Ouermi D., Bisseye C., Sagna T., Odolini S., et al. Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa. Braz J Infect Dis 2010, 14:219-224.
34. Xu W.M., Cui Y.T., Wang L., Yang H., Liang Z.Q., Li X.M., et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009, 16:94-103.
35. Institut de Recherche pour le Développement; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Centers for Disease Control and Prevention, Gilead Sciences. Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand (iTAP). ClinicalTrials.gov [Internet] 2000, National Library of Medicine, US, Bethesda, MD, Available from: http://clinicaltrials.gov/ct2/show/NCT01745822?term=NCT01745822&rank=1 (assessed 14.04.13). NLM Identifier: NCT01745822.